By Benjamin Chiou
Date: Thursday 19 Sep 2024
(Sharecast News) - Angle's share price received a boost on Thursday after the liquid biopsy company announced a new agreement with Utah-based biotech firm Recursion Pharmaceuticals.
Half-year Report | 26-Sep-2024 | 07:00 | RNS |
Exclusive agreement for DNA NGS panel | 23-Sep-2024 | 07:00 | RNS |
Notice of Interim Results and Webcast | 17-Sep-2024 | 07:00 | RNS |
Standard form for notification of major holdings | 18-Jul-2024 | 10:08 | RNS |
Standard form for notification of major holdings | 12-Jul-2024 | 15:38 | RNS |
Market report: Monday latest | 07-Apr-2008 | Daily Mail |
T&T float sinks amid turmoil | 07-Feb-2008 | Times |
Carphone buzz may just be empty static | 01-Feb-2008 | Guardian |
Greene King looks to life after cigarette ban | 02-Jul-2007 | The Independent |
The Week Ahead: BSkyB boosted by 200,000 new sub... | 29-Jan-2007 | The Independent |
No recent information was found.
Currency | UK Pounds |
Share Price | 11.00p |
Change Today | -0.50p |
% Change | -4.35 % |
52 Week High | 31.35 |
52 Week Low | 7.25 |
Volume | 1,104,485 |
Shares Issued | 322.64m |
Market Cap | £35.49m |
Beta | 0.79 |
RiskGrade | 312 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
17:05 | 158,846 @ 11.00p |
15:08 | 1,844 @ 10.73p |
15:05 | 87,930 @ 10.73p |
13:34 | 4,700 @ 10.73p |
13:28 | 50,000 @ 10.89p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research